Christopher R D'Angelo (Christopher D'Angelo)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Cancer research communications

JCO oncology practice

Transplant infectious disease : an official journal of the Transplantation Society

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer research communications 4 (5) (2024)
Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects. Cancer research communications (2024)
Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer research communications 4 (5) (2024)
Magdi Elsallab, Moataz Ellithi, Matthew A Lunning, Christopher R D'Angelo, Jihyun Ma, Miguel-Ángel Perales, Matthew Frigault, Marcela V Maus
Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA Adverse Events Reporting System. Blood 143 (20) (2024)
Christopher R D'Angelo
Diagnostic, Pathologic, and Therapeutic Considerations for Primary CNS Lymphoma. JCO oncology practice (2023)
Olivia L Makos, Christopher R D'Angelo
The shifting roles and toxicities of cellular therapies in B-cell malignancies. Transplant infectious disease : an official journal of the Transplantation Society (2023)
Juan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, Graham P Collins, Alexey V Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher R D'Angelo, Umar Farooq, David A Bond, Stephanie Berg, Michael C Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Sarraf Yazdy, Emma Rabinovich, Frank A Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine S Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M Haverkos, Victor M Orellana-Noia, Vaishalee P Kenkre, Adam Stephen Zayac, Seth M Maliske, Narendranath Epperla, Paolo Caimi, Scott E Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A Feldman, Daniel Rector, Stephen Douglas Smith, Andrzej Stadnik, Craig A Portell, Yong Lin, Seema G Naik, Silvia Montoto, Izidore S Lossos, Kate Cwynarski
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. Blood advances 5 (14) (2021)
Christopher R D'Angelo, Sailendharan Sudakaran, Natalie S Callander
Clinical effects and applications of the gut microbiome in hematologic malignancies. Cancer 127 (5) (2020)